These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25540846)

  • 1. Red blood cells as bioindicators of cardiovascular risk in Kawasaki disease: A case report.
    Pietraforte D; Gambardella L; Marchesi A; de Jacobis IT; Viora M; Del Principe D; Villani A; Malorni W; Straface E
    Int J Cardiol; 2015 Feb; 181():311-3. PubMed ID: 25540846
    [No Abstract]   [Full Text] [Related]  

  • 2. Incomplete Kawasaki disease: a pediatric diagnostic conflict.
    Celik U; Alhan E; Arabaci F
    Anadolu Kardiyol Derg; 2007 Sep; 7(3):343-4. PubMed ID: 17785242
    [No Abstract]   [Full Text] [Related]  

  • 3. Does oxidative stress play a critical role in cardiovascular complications of Kawasaki disease?
    Straface E; Marchesi A; Gambardella L; Metere A; Tarissi de Jacobis I; Viora M; Giordani L; Villani A; Del Principe D; Malorni W; Pietraforte D
    Antioxid Redox Signal; 2012 Nov; 17(10):1441-6. PubMed ID: 22578402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microscopic polyangiitis and Kawasaki disease without overt clinical cardiovascular manifestations and with abnormal cardiovascular magnetic resonance findings.
    Mavrogeni S; Papadopoulos G; Karanasios E; Georgakopoulos D; Manoussakis MN
    Int J Cardiol; 2010 May; 141(1):e17-9. PubMed ID: 19135271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular involvement in Kawasaki disease.
    Narayanan SN; Ahamed MZ; Safia M
    Indian Pediatr; 2005 Sep; 42(9):918-22. PubMed ID: 16208052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kawasaki syndrome: the Iranian experience.
    Sadeghi E; Amin R; Ajamee GH
    East Mediterr Health J; 2001; 7(1-2):16-25. PubMed ID: 12596947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kawasaki syndrome--cardiovascular manifestations.
    Rose V
    J Rheumatol Suppl; 1990 Sep; 24():11-4. PubMed ID: 1700119
    [No Abstract]   [Full Text] [Related]  

  • 8. Kawasaki disease: a case report and overview of symptoms, signs, investigations and treatment.
    Almeida B; Gleeson P; Chawla K; Brogan P
    Br J Hosp Med (Lond); 2012 Feb; 73(2):C26-8. PubMed ID: 22504712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease.
    Japanese Circulation Society Joint Research Group
    Pediatr Int; 2005 Dec; 47(6):711-32. PubMed ID: 16354233
    [No Abstract]   [Full Text] [Related]  

  • 10. What do we know about Kawasaki disease?
    Kucińska B; Wróblewska-Kałuzewska M
    Med Sci Monit; 2000; 6(6):1227-31. PubMed ID: 11208484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardiovascular complications in Kawasaki syndrome].
    Lambert V
    Arch Pediatr; 2008 Jun; 15(5):829-31. PubMed ID: 18582768
    [No Abstract]   [Full Text] [Related]  

  • 12. Kawasaki disease in a patient with Wiskott-Aldrich syndrome: an increase in the platelet count.
    Kawakami C; Miyake M; Tamai H
    Int J Hematol; 2003 Feb; 77(2):199-200. PubMed ID: 12627860
    [No Abstract]   [Full Text] [Related]  

  • 13. [Kawasaki disease in Mexico: an analysis of 13 cases].
    González-Galnares M; Urbán-Vázquez H; Santamaría-Díaz H; Gorbea-Robles MC
    Bol Med Hosp Infant Mex; 1991 Jun; 48(6):409-16. PubMed ID: 1910555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2003)].
    J Cardiol; 2004 Apr; 43(4):263-83. PubMed ID: 15125385
    [No Abstract]   [Full Text] [Related]  

  • 15. [Kawasaki disease (mucocutaneous lymph node syndrome). Report of 7 cases and brief review].
    Sakane PT; de Mendonça JS; Mazzucato G; Pannuti CS; Amato Neto V
    Rev Paul Med; 1983; 101(2):62-7. PubMed ID: 6622895
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical evolution and cardiovascular complications in children with Kawasaki disease].
    Morales-Quispe JA; Espinola-Zavaleta N; Caballero-Caballero R; García-López Jde J; Rodríguez-Quezada JM; Betanzos-Rodríguez L
    Rev Med Inst Mex Seguro Soc; 2011; 49(3):295-300. PubMed ID: 21838997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kawasaki disease shock syndrome: Case report and cytokine profiling.
    Ono R; Shimizu M; Yamamoto K; Umehara N; Manabe A
    Pediatr Int; 2019 Jun; 61(6):620-622. PubMed ID: 31216599
    [No Abstract]   [Full Text] [Related]  

  • 18. Kawasaki disease: part I. Diagnosis, clinical features, and pathogenesis.
    Bayers S; Shulman ST; Paller AS
    J Am Acad Dermatol; 2013 Oct; 69(4):501.e1-11; quiz 511-2. PubMed ID: 24034379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular Risk After Kawasaki Disease - Findings From an Australian Case-Control Study.
    Chen KYH; Curtis N; Cheung M; Burgner D
    Heart Lung Circ; 2018 Jan; 27(1):6-8. PubMed ID: 29198833
    [No Abstract]   [Full Text] [Related]  

  • 20. Characteristics of Kawasaki disease in infants younger than six months of age.
    Chang FY; Hwang B; Chen SJ; Lee PC; Meng CC; Lu JH
    Pediatr Infect Dis J; 2006 Mar; 25(3):241-4. PubMed ID: 16511387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.